ProShare Advisors LLC Increases Position in Alignment Healthcare, Inc. $ALHC

ProShare Advisors LLC lifted its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 20.7% in the 2nd quarter, Holdings Channel reports. The firm owned 26,152 shares of the company’s stock after purchasing an additional 4,485 shares during the quarter. ProShare Advisors LLC’s holdings in Alignment Healthcare were worth $366,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Victory Capital Management Inc. increased its position in shares of Alignment Healthcare by 905.7% in the first quarter. Victory Capital Management Inc. now owns 114,397 shares of the company’s stock valued at $2,130,000 after buying an additional 103,022 shares in the last quarter. Raymond James Financial Inc. grew its stake in Alignment Healthcare by 31.1% in the 1st quarter. Raymond James Financial Inc. now owns 206,174 shares of the company’s stock valued at $3,839,000 after acquiring an additional 48,901 shares during the last quarter. Strs Ohio purchased a new position in Alignment Healthcare during the 1st quarter valued at about $600,000. Acadian Asset Management LLC increased its holdings in Alignment Healthcare by 1,025.2% during the 1st quarter. Acadian Asset Management LLC now owns 375,949 shares of the company’s stock valued at $6,992,000 after acquiring an additional 342,537 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. raised its position in Alignment Healthcare by 101.5% during the first quarter. Adage Capital Partners GP L.L.C. now owns 69,497 shares of the company’s stock worth $1,294,000 after acquiring an additional 35,000 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the stock. Zacks Research cut shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 28th. JPMorgan Chase & Co. increased their target price on Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a report on Wednesday, November 5th. Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. KeyCorp upgraded Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price objective on the stock in a research report on Monday, August 25th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Alignment Healthcare presently has an average rating of “Moderate Buy” and an average price target of $19.85.

Insider Transactions at Alignment Healthcare

In related news, President Dawn Christine Maroney sold 215,662 shares of Alignment Healthcare stock in a transaction on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $3,539,013.42. Following the transaction, the president owned 1,797,237 shares in the company, valued at approximately $29,492,659.17. The trade was a 10.71% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the company’s stock in a transaction on Wednesday, September 17th. The stock was sold at an average price of $16.01, for a total transaction of $99,999,996.96. Following the sale, the director directly owned 24,596,079 shares of the company’s stock, valued at approximately $393,783,224.79. This trade represents a 20.25% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 7,569,148 shares of company stock valued at $122,000,105 in the last three months. 7.00% of the stock is owned by company insiders.

Alignment Healthcare Trading Up 3.9%

Shares of ALHC opened at $16.70 on Friday. Alignment Healthcare, Inc. has a twelve month low of $10.18 and a twelve month high of $21.06. The firm has a market capitalization of $3.34 billion, a P/E ratio of -139.17 and a beta of 1.17. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. The stock’s fifty day simple moving average is $16.98 and its 200 day simple moving average is $15.41.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, October 30th. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.03. The company had revenue of $993.70 million during the quarter, compared to analyst estimates of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The firm’s revenue was up 43.5% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.14) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. On average, equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.